๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hepatitis B, Chronic
Clinical trial register · China

Hepatitis B, Chronic Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 6 Beijing 3 Shanghai 3 Chongqing 2 Nanjing 2
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou6 Beijing3 Shanghai3 Chongqing2 Nanjing2
All 24 locations
Target enrolment
to

Hepatitis B, Chronic trials in China

16 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Efficacy and Safety of Pegylated Interferon Alpha-2ฮฒ in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
NCT07553767Hepatocellular Carcinoma, HEPATITIS B CHRONIC, Hepatitis B Chronic Infection
Ningbo No.2 Hospital
Phase EARLY_PHASE1
156
Hangzhou, Ningbo
2026-03-31
Recruiting
Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
NCT07370207Hepatitis B, Chronic
AusperBio Therapeutics Inc.
Phase 2
84
Hong Kong
2026-03-06
Recruiting
Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens
NCT06923280Hepatitis B, Chronic
Huashan Hospital
Not applicable
72
Beijing, Shanghai
2025-08-25
Active, closed
A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B
NCT07555340HEPATITIS B CHRONIC
Juan Li
Observational
400
Zhengzhou
2024-12-30
Recruiting
Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
NCT06550622Hepatitis B, Chronic
Huashan Hospital
Observational
300
Shanghai
2024-08-10
Not yet open
A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B
NCT06452693Hepatitis B, Chronic
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
162
Bengbu, Fuzhou, Lanzhou, Guangzhou, Nanning, Guiyang, Harbin, Shiyan
2024-06
Recruiting
A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
NCT06525909Hepatitis B, Chronic
Tongji Hospital
Observational
250
Wuhan, Beijing, Changchun, Chongqing, Nanjing
2024-01-20
Recruiting
Efficacy of NA Combined With PEG-IFN-ฮฑ2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B
NCT05922306Hepatitis B, Chronic
Anhui Medical University
Phase EARLY_PHASE1
1,084
Hefei
2023-07
Recruiting
HBsAg Declined Patients Follow-up Study
NCT05977283Hepatitis B, Hepatitis B, Chronic
Nanfang Hospital, Southern Medical University
Observational
100
Guangzhou
2023-05-11
Recruiting
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
NCT05870969Carcinoma, Hepatocellular, Hepatitis C, Chronic, Hepatitis B, Chronic, Cirrhosis, Liver
Ruijin Hospital
Observational
20,000
Shanghai
2023-03-01
Recruiting
Real-world Study Optimizing Nucleotide-analogues
NCT05937178Hepatitis B, Chronic
Huashan Hospital
Observational
20,000
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Nanning, Guiyang
2023-01-31
Active, closed
Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB
NCT06743438Hepatitis B, Chronic
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 4
640
Guangzhou
2022-03-10
Recruiting
Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients
NCT05182463Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University
Phase 4
5,000
Guangzhou
2022-01-08
Recruiting
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
NCT04597164Hepatitis B, Chronic, Acute-On-Chronic Liver Failure
Third Affiliated Hospital, Sun Yat-Sen University
Observational
200
Guangzhou
2020-12-22
Active, closed
The Clinical Cure Project of Chronic Hepatitis B in China
NCT04035837Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University
Phase 4
30,000
Guangzhou
2018-05-16
Recruiting
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
NCT03097952Hepatitis B๏ผŒ Chronic
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
20,000
Changzhou, Huai'an, Nanjing, Suqian, Suzhou
2008-01
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/hepatitis-b-chronic

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies listing the condition Hepatitis B, Chronic.

How many Hepatitis B, Chronic trials are recruiting in China?

11 of the 16 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hepatitis B, Chronic), 16 studies
PhaseStudiesRecruitingShare
Observational8750%
Phase 43118.8%
Phase EARLY_PHASE12112.5%
Not applicable116.3%
Phase 1/2106.3%
Phase 2116.3%

Most active sponsors

Lead sponsors with the most studies (Hepatitis B, Chronic)
Lead sponsorStudiesRecruiting
Huashan Hospital33
Third Affiliated Hospital, Sun Yat-Sen University32
Anhui Medical University11
AusperBio Therapeutics Inc.11
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.10
Jiangsu Hansoh Pharmaceutical Co., Ltd.10
Juan Li10
Nanfang Hospital, Southern Medical University11
Ningbo No.2 Hospital10
Ruijin Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.